October 2017 - Volume 23 - Issue 10 - Contributor Index

SHANK3 Regulates Intestinal Barrier Function Through Modulating ZO-1 Expression Through the PKCε-dependent Pathway

Wei, Shu-Chen; Yang-Yen, Hsin-Fang; Tsao, Po-Nien; More

Inflammatory Bowel Diseases. 23(10):1730-1740, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

IBD LIVE Series—Case 8: Treatment Options for Refractory Esophageal Crohn's Disease and Hidradenitis Suppurativa

Iskandar, Heba; Greer, Julia B.; Krasinskas, Alyssa M.; More

Inflammatory Bowel Diseases. 23(10):1667-1677, October 2017.

  • Video
Author:
Li, Li MD

Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn's Disease

Feng, Ting; Chen, Baili; Li, Li; More

Inflammatory Bowel Diseases. 23(10):1817-1824, October 2017.

Author:
Li, Manying MD

Serum Interleukin 9 Levels Predict Disease Severity and the Clinical Efficacy of Infliximab in Patients with Crohn's Disease

Feng, Ting; Chen, Baili; Li, Li; More

Inflammatory Bowel Diseases. 23(10):1817-1824, October 2017.

Author:
Li, Shawn X. BS

Delivering High Value Inflammatory Bowel Disease Care Through Telemedicine Visits

Li, Shawn X.; Thompson, Kimberly D.; Peterson, Tracey; More

Inflammatory Bowel Diseases. 23(10):1678-1681, October 2017.

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

Guerbau, Loic; Gerard, Romain; Duveau, Nicolas; More

Inflammatory Bowel Diseases. 23(10):1853-1859, October 2017.

Author:
Lin, Jay PhD

Comparison of Health Care Utilization and Costs Between Patients with Perianal Fistulizing Crohn's Disease Treated with Biologics with or Without Previous Seton Placement

Schwartz, David A.; Wang, Anthony; Ozbay, Burak; More

Inflammatory Bowel Diseases. 23(10):1860-1866, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.

Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort

Bramuzzo, Matteo; Stocco, Gabriele; Montico, Marcella; More

Inflammatory Bowel Diseases. 23(10):1810-1816, October 2017.